Cerus (CERS) EBITDA Margin (2009 - 2026)
Cerus (CERS) reported EBITDA Margin of 1.39% for Q3 2026, down 1.68 percentage points from 3.07% a year earlier but up 3.83 percentage points from the prior quarter.
Powered by 
Analysis
Cerus (CERS) EBITDA Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Cerus' EBITDA Margin came in at 0.44%, up 7.14 percentage points year-over-year; for FY2021, it came in at -28.70%, up 19.63 percentage points from FY2020.
- EBITDA Margin has increased for six consecutive years, with a five-year change of +123.12 percentage points (FY2016 to FY2021).
- By year, EBITDA Margin came in at -48.34% in FY2020 (+19.72 pp), -68.06% in FY2019 (+2.34 pp), -70.40% in FY2018 (+38.15 pp) and -108.56% in FY2017 (+43.27 pp).
- Five-year quarterly EBITDA Margin spans a low of -20.88% in Q1 2022 and a high of 3.07% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 20.05% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 9.79% |
| 10 | Cerus | 393.81 Mn | 117.79 Mn | 30.27 Mn | 1.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.39% |
| Jun 30, 2026 | -2.43% |
| Mar 31, 2026 | 0.17% |
| Dec 31, 2025 | -0.29% |
| Sep 30, 2025 | 3.07% |
| Jun 30, 2025 | -5.87% |
| Mar 31, 2025 | -12.83% |
| Dec 31, 2024 | -1.97% |
| Sep 30, 2024 | -1.08% |
| Jun 30, 2024 | -6.64% |
| Mar 31, 2024 | -16.93% |
| Dec 31, 2023 | 3.04% |
| Sep 30, 2023 | -9.66% |
| Jun 30, 2023 | -23.05% |
| Mar 31, 2023 | -35.12% |
| Dec 31, 2022 | -18.13% |
| Sep 30, 2022 | -14.54% |
| Jun 30, 2022 | -12.75% |
| Mar 31, 2022 | -20.88% |
| Dec 31, 2021 | -12.28% |
API Access
Cerus EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();